HomeOLMA • NASDAQ
add
Olema Pharmaceuticals Inc
Previous close
$9.85
Day range
$9.44 - $10.24
Year range
$5.02 - $17.79
Market cap
540.32M USD
Avg Volume
725.56K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 34.34M | 28.12% |
Net income | -30.97M | -9.49% |
Net profit margin | — | — |
Earnings per share | -0.56 | 20.00% |
EBITDA | -34.25M | -28.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 248.98M | 33.89% |
Total assets | 263.69M | 34.70% |
Total liabilities | 27.38M | 31.66% |
Total equity | 236.32M | — |
Shares outstanding | 55.89M | — |
Price to book | 2.33 | — |
Return on assets | -31.76% | — |
Return on capital | -34.70% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -30.97M | -9.49% |
Cash from operations | -23.50M | -15.23% |
Cash from investing | -20.14M | -153.88% |
Cash from financing | 8.82M | 3,909.55% |
Net change in cash | -34.82M | -302.25% |
Free cash flow | -10.49M | -30.84% |
About
Founded
2006
Headquarters
Website
Employees
76